CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the UBS 2008 Global Life Sciences conference on Tuesday, September 23, 2008, at 1:30 p.m. ET at the Grand Hyatt New York in New York City.
